Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Agaricus blazei Murill (ABM) is one of the most popular complementary alternative medicines (CAM). We experienced a case of a 60-year-old woman with severe hepatitis associated with extract of ABM and extract of Ganoderma lucidum, and a case of a 75-year-old man with drug-induced liver injury (DILI) associated with extract of ABM and fucoidan. Their clinical courses from the start of CAM until the onset of DILI were observed unexpectedly, because they were under observation for stable malignant neoplasms: stage III malignant thymoma and stage IV lung cancer, respectively. However, they did not talk about taking CAM with their physicians. There were two common points between these two cases. First, they were diagnosed as compatible with DILI by using an international diagnostic scale, the Roussel Uclaf Causality Assessment Method. The second point was that histological findings of the liver were very similar to autoimmune hepatitis (AIH). In addition, serum immunoglobulin G and zinc sulfate turbidity tests gradually increased from the start of CAM to the onset of DILI. Their clinical course and liver histology suggested that the immunostimulating action of ABM caused liver injury which was very similar to that seen in AIH.
- Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, et al. Nationwide survey on complementary alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23:2645–54. CrossRef
- Girgis A, Adams J, Sibbritt D. The use of complementary and alternative therapies by patients with cancer. Oncol Res. 2005;15:281–9.
- Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340:1733–9. CrossRef
- Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179:407–11. CrossRef
- Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002;8:477–85. CrossRef
- Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Ito H, et al. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res. 1989;186:267–73. CrossRef
- Mizuno M, Morimoto M, Minato K, Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem. 1998;62:434–7. CrossRef
- Takeda K, Okumura K. CAM and NK cells. eCAM. 2004;1:17–27.
- Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of International consensus meetings: application to drug-Induced liver injuries. J Clin Epidemiol. 1993;46:1323–30. CrossRef
- Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38. CrossRef
- Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76. CrossRef
- Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin. 1992;42:181–91. CrossRef
- Metz JM, Jones H, Devine P, Hahn S, Glastein E. Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. Cancer J. 2001;7:149–54.
- Wanmuanq H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai. 2007;90:179–81.
- Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune Hepatitis, a study of 68 patients. J Clin Gastroenterol. 2002;35:75–81. CrossRef
- Hegarty JE, Nouri Aria KT, Portmann B, Eddleston AL, Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983;3:685–9. CrossRef
- Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission. Gastroenterology. 1980;78:518–23.
- Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sc. 1965;124:767–80. CrossRef
- Sorimachi K, Akimoto K, Yamazaki S, Niwa A, Toda S, Yasumura Y. Multinucleation of macrophages with water-solubilized lignin derivatives in vitro. Cell Struct Funct. 1990;15:317–22. CrossRef
- Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol. 1997;26:1207–12. CrossRef
- Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991;88:1370–8. CrossRef
- Takikawa H, Murata Y, Horiike N, Fukui H, Onji M. Drug-induced liver injury in Japan: an analysis of 1676 cases between 1997 and 2006. Hepatol Res. 2009;39:427–31. CrossRef
- Mukai H, Watanabe T, Ando M, Katsumata N. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol. 2006;36:808–10. CrossRef
- Onji M, Takikawa H, Murata Y, Hashimoto N, Kojima Y, Hisamochi A, et al. Surveillance of folk medicine-induced hepatitis. Kanzo. 2005;46:142–8. (in Japanese). CrossRef
- Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW. Fatal fulminant hepatic failure induced by natural therapy containing kava. Med J Aust. 2003;178:442–3.
- National Center for Complementary and Alternative Medicine. Kava Linked to Liver Damage. [Cited 30 Oct 2012]. Available from URL: http://nccam.nih.gov/news/alerts/kava/.
- Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis
Clinical Journal of Gastroenterology
Volume 6, Issue 2 , pp 139-144
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Drug-induced liver injury
- Autoimmune hepatitis
- Liver histology
- Agaricus blazei Murill
- Complementary alternative medicines
- Author Affiliations
- 1. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan
- 4. Hisamochi Medical Office, 46 Maruyama-cho, Nakatsu, Oita, 871-0047, Japan
- 2. The Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan
- 3. Office of Medical Education, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan